Robert N. Hoover researcher
Hoover, Robert N.
Hoover, Robert N., 1942-
VIAF ID: 286198389 (Personal)
Permalink: http://viaf.org/viaf/286198389
Preferred Forms
-
-
- 100 1 _ ‡a Hoover, Robert N.
- 100 1 _ ‡a Hoover, Robert N., ‡d 1942-
- 100 0 _ ‡a Robert N. Hoover ‡c researcher
Works
Title | Sources |
---|---|
The emerging epidemic of Non-Hodgkin's lymphoma : current knowledge regarding etiological factors, held at National Institutes of Health Bethesda, Maryland October 22-23, 1991 | |
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer | |
Performance of common genetic variants in breast-cancer risk models | |
Perinatal characteristics and bone cancer risk in offspring--a Scandinavian population-based study | |
Perinatal factors, growth and development, and osteosarcoma risk | |
Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies | |
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. | |
Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts | |
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | |
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. | |
Pooling prospective studies to investigate the etiology of second cancers | |
Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States | |
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women | |
Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? | |
Pregnancy characteristics and maternal risk of breast cancer | |
Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk | |
Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations | |
Prenatal DES exposure in relation to breast size | |
Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract | |
Prenatal diethylstilbestrol exposure and risk of diabetes, gallbladder disease, and pancreatic disorders and malignancies | |
Prevalence of a history of testicular cancer in a cohort of elderly twins | |
Prevalence of BPH and lower urinary tract symptoms in West Africans. | |
Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer | |
Proportion of breast cancer cases in the United States explained by well-established risk factors | |
Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | |
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium | |
Pubertal timing and breast density in young women: a prospective cohort study | |
Quantifying epidemiologic risk factors using non‐parametric regression: model selection remains the greatest challenge | |
Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association. | |
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3) | |
Racial differences in bladder cancer risk: a case-control study | |
Racial differences in serum immunoglobulin levels: relationship to cigarette smoking, T-cell subsets, and soluble interleukin-2 receptors | |
Random digit dialing in selecting a population-based control group | |
Rauwolfia use and breast cancer: a case-control study | |
Re: "Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability" | |
Re: "Tests for trend and dose response: misinterpretations and alternatives" | |
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. | |
Relative weight, weight change, height, and breast cancer risk in Asian-American women | |
Reply | |
Reply to 'Mosaic loss of chromosome Y in leukocytes matters' | |
Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. | |
Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone | |
Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study | |
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study | |
Reproductive outcomes in men with prenatal exposure to diethylstilbestrol | |
Response: Re: Mortality From Lymphohematopoietic Malignancies and Brain Cancer Among Embalmers Exposed to Formaldehyde | |
Response to Tarone and McLaughlin: RE: Mortality from solid tumors in the updated NCI formaldehyde worker cohort | |
Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results | |
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status | |
Rising incidence of breast cancer: relationship to stage and receptor status | |
Risk of astrocytic brain tumors associated with occupational chemical exposures. A case-referent study. | |
Risk of connective tissue disorders among breast implant patients. | |
Risk of leukemia after chemotherapy and radiation treatment for breast cancer | |
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study | |
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States | |
Risk of multiple myeloma in a case-spouse study | |
Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? | |
Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma | |
Secondary sex ratio among women exposed to diethylstilbestrol in utero | |
Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study | |
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions | |
Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey | |
Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women | |
Serum concentrations of organochlorine compounds and endometrial cancer risk (United States). | |
Serum estrogen and androgen levels following treatment for cervical cancer | |
Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). | |
Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites | |
Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer | |
Service in Vietnam and risk of testicular cancer | |
Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women | |
Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer | |
Sexual behaviour, STDs and risks for prostate cancer | |
TMPRSS2-ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-analysis of Racial Differences |